Logo image of DSM.CA

DEEP-SOUTH RESOURCES INC (DSM.CA) Stock Fundamental Analysis

Canada - TSX-V:DSM - CA24378W1032 - Common Stock

0.08 CAD
0 (0%)
Last: 3/20/2024, 7:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to DSM. DSM was compared to 805 industry peers in the Metals & Mining industry. While DSM has a great health rating, there are worries on its profitability. DSM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

DSM had negative earnings in the past year.
DSM had a negative operating cash flow in the past year.
In the past 5 years DSM always reported negative net income.
In the past 5 years DSM always reported negative operating cash flow.
DSM.CA Yearly Net Income VS EBIT VS OCF VS FCFDSM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 -2M -4M -6M -8M

1.2 Ratios

DSM has a Return On Assets of -712.26%. This is amonst the worse of the industry: DSM underperforms 95.45% of its industry peers.
DSM's Return On Equity of -753.87% is on the low side compared to the rest of the industry. DSM is outperformed by 85.01% of its industry peers.
Industry RankSector Rank
ROA -712.26%
ROE -753.87%
ROIC N/A
ROA(3y)-255.92%
ROA(5y)-158.24%
ROE(3y)-281.31%
ROE(5y)-174.67%
ROIC(3y)N/A
ROIC(5y)N/A
DSM.CA Yearly ROA, ROE, ROICDSM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 200 -200 400 -400 -600

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for DSM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DSM.CA Yearly Profit, Operating, Gross MarginsDSM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022

More info and screens

8

2. Health

2.1 Basic Checks

Compared to 1 year ago, DSM has more shares outstanding
There is no outstanding debt for DSM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DSM.CA Yearly Shares OutstandingDSM.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M
DSM.CA Yearly Total Debt VS Total AssetsDSM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M

2.2 Solvency

An Altman-Z score of 97.07 indicates that DSM is not in any danger for bankruptcy at the moment.
DSM's Altman-Z score of 97.07 is amongst the best of the industry. DSM outperforms 94.47% of its industry peers.
There is no outstanding debt for DSM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 97.07
ROIC/WACCN/A
WACCN/A
DSM.CA Yearly LT Debt VS Equity VS FCFDSM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 2M -2M 4M -4M 6M 8M

2.3 Liquidity

DSM has a Current Ratio of 8.46. This indicates that DSM is financially healthy and has no problem in meeting its short term obligations.
DSM has a better Current ratio (8.46) than 79.12% of its industry peers.
A Quick Ratio of 8.46 indicates that DSM has no problem at all paying its short term obligations.
The Quick ratio of DSM (8.46) is better than 79.12% of its industry peers.
Industry RankSector Rank
Current Ratio 8.46
Quick Ratio 8.46
DSM.CA Yearly Current Assets VS Current LiabilitesDSM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 500K 1M 1.5M 2M

More info and screens

0

3. Growth

3.1 Past

DSM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -424.93%.
EPS 1Y (TTM)-424.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.21%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

DSM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DSM.CA Price Earnings VS Forward Price EarningsDSM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DSM.CA Per share dataDSM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.02 -0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

DSM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DEEP-SOUTH RESOURCES INC

TSX-V:DSM (3/20/2024, 7:00:00 PM)

0.08

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)02-04 2022-02-04
Inst Owners0.63%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap0
Revenue(TTM)N/A
Net Income(TTM)-8937240
Analysts84.44
Price Target1.07 (1237.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 11.43
P/tB 11.43
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -712.26%
ROE -753.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-255.92%
ROA(5y)-158.24%
ROE(3y)-281.31%
ROE(5y)-174.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1647.66%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.46
Quick Ratio 8.46
Altman-Z 97.07
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-424.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.21%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y38.34%
OCF growth 3YN/A
OCF growth 5YN/A